Hepatosplenic T-cell lymphoma in adolesc
✍
Joel R. Rosh; Thomas Gross; Petar Mamula; Anne Griffiths; Jeffrey Hyams
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 130 KB
👁 1 views
Therapy for the inflammatory bowel diseases increasingly includes the use of immune-modifying and biologic therapies. Recently, in young patients with IBD, an association has been noted between the use of infliximab along with concomitant purine analogues and the development of hepatosplenic T-cell